Schedule Of Common Shares

6,500 Common Shares of Oncology Pharma, Inc.

Basis

Fair Value

Total Unrealized Losses

Net Unrealized Gain or (Loss) realized during the Quarter ended December 31,2021

$

177,450

$

26,325

$

(151125

)

$

(44,005)